IL140151A0 - Hyperforin derivatives, the use thereof and formulations containing them - Google Patents

Hyperforin derivatives, the use thereof and formulations containing them

Info

Publication number
IL140151A0
IL140151A0 IL14015199A IL14015199A IL140151A0 IL 140151 A0 IL140151 A0 IL 140151A0 IL 14015199 A IL14015199 A IL 14015199A IL 14015199 A IL14015199 A IL 14015199A IL 140151 A0 IL140151 A0 IL 140151A0
Authority
IL
Israel
Prior art keywords
formulations containing
hyperforin derivatives
hyperforin
derivatives
glicoside
Prior art date
Application number
IL14015199A
Other languages
English (en)
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of IL140151A0 publication Critical patent/IL140151A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/647—Unsaturated compounds containing a keto groups being part of a ring having unsaturation outside the ring
    • C07C49/653—Unsaturated compounds containing a keto groups being part of a ring having unsaturation outside the ring polycyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14015199A 1998-06-10 1999-06-04 Hyperforin derivatives, the use thereof and formulations containing them IL140151A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI001312A IT1301679B1 (it) 1998-06-10 1998-06-10 Derivati dell'iperforina, loro uso e formulazioni che licontengono.
PCT/EP1999/003880 WO1999064388A1 (en) 1998-06-10 1999-06-04 Hyperforin derivatives, the use thereof and formulations containing them

Publications (1)

Publication Number Publication Date
IL140151A0 true IL140151A0 (en) 2002-02-10

Family

ID=11380210

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14015199A IL140151A0 (en) 1998-06-10 1999-06-04 Hyperforin derivatives, the use thereof and formulations containing them
IL140151A IL140151A (en) 1998-06-10 2000-12-07 Hyperforin derivatives are used by Ben and the compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL140151A IL140151A (en) 1998-06-10 2000-12-07 Hyperforin derivatives are used by Ben and the compositions containing them

Country Status (23)

Country Link
US (1) US6656510B2 (it)
EP (2) EP1607099A1 (it)
JP (1) JP4511726B2 (it)
KR (1) KR100627933B1 (it)
CN (1) CN1246278C (it)
AT (1) ATE307103T1 (it)
AU (1) AU763889B2 (it)
BR (1) BR9910893B1 (it)
CA (1) CA2334308C (it)
CZ (1) CZ298859B6 (it)
DE (1) DE69927813T2 (it)
DK (1) DK1086071T3 (it)
ES (1) ES2249893T3 (it)
HK (1) HK1036791A1 (it)
HU (1) HUP0102226A3 (it)
IL (2) IL140151A0 (it)
IT (1) IT1301679B1 (it)
MX (1) MXPA00012177A (it)
NO (1) NO328444B1 (it)
PL (1) PL195797B1 (it)
RU (1) RU2240304C2 (it)
SK (1) SK286049B6 (it)
WO (1) WO1999064388A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1770700A (en) * 1998-11-04 2000-05-22 Dr. Willmar Schwabe Gmbh & Co Stable preparations with hyperforin
ITMI20020871A1 (it) 2002-04-23 2003-10-23 Indena Spa Derivati alogenati dell'iperforina loro uso e formulazioni che li contengono
ITMI20020872A1 (it) * 2002-04-23 2003-10-23 Indena Spa Derivati dell'iperforina loro uso e formulazioni che li contengono
US20060115555A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts
BRPI0900614A2 (pt) 2009-02-13 2011-06-28 Univ Fed Do Rio Grande Do Sul Ufrgs extrato vegetal neuroativo, composição farmacêutica compreendendo o mesmo e processo para sua produção
BR112013030986A2 (pt) * 2011-06-03 2016-12-06 Harvard College análogos de hiperforina, métodos de síntese e usos dos mesmos
ITMI20131012A1 (it) 2013-06-19 2014-12-20 Indena Spa Derivati dell'iperforina e loro uso nella malattia di alzheimer
RU2676100C1 (ru) * 2018-10-05 2018-12-26 федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский политехнический университет Петра Великого" (ФГАОУ ВО "СПбПУ") Применение производных пиперазина для лечения болезни Альцгеймера и деменций альцгеймеровского типа с нарушенной внутриклеточной кальциевой сигнализацией

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2550266A (en) * 1948-12-11 1951-04-24 Swift & Co Preservation of food products
DE4239959A1 (de) * 1992-11-27 1994-06-01 Schwabe Willmar Gmbh & Co Johanniskraut-Trockenextrakt, Verfahren zu seiner Herstellung und seine Verwendung
DE19646977A1 (de) * 1995-09-29 1998-01-15 Schwabe Willmar Gmbh & Co Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen
DE19714450A1 (de) * 1997-04-08 1998-10-15 Schwabe Willmar Gmbh & Co Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitung
AU746072B2 (en) * 1998-01-13 2002-04-11 Rexall Sundown, Inc. St. John's wort and methyl donor composition and uses thereof
US6224906B1 (en) * 1999-08-31 2001-05-01 Natreon Inc. St. John's wort composition

Also Published As

Publication number Publication date
PL195797B1 (pl) 2007-10-31
EP1607099A1 (en) 2005-12-21
DK1086071T3 (da) 2006-01-23
ES2249893T3 (es) 2006-04-01
CZ20004562A3 (en) 2001-06-13
BR9910893A (pt) 2001-03-06
IT1301679B1 (it) 2000-07-07
SK286049B6 (sk) 2008-01-07
DE69927813T2 (de) 2006-04-20
JP2002517478A (ja) 2002-06-18
HUP0102226A2 (hu) 2001-10-28
IL140151A (en) 2006-12-10
AU4373999A (en) 1999-12-30
HUP0102226A3 (en) 2003-07-28
AU763889B2 (en) 2003-07-31
PL344696A1 (en) 2001-11-19
ATE307103T1 (de) 2005-11-15
US20010020040A1 (en) 2001-09-06
SK18712000A3 (sk) 2001-06-11
RU2240304C2 (ru) 2004-11-20
NO20006230L (no) 2001-02-01
JP4511726B2 (ja) 2010-07-28
DE69927813D1 (de) 2006-03-02
HK1036791A1 (en) 2002-01-18
CN1246278C (zh) 2006-03-22
CN1304397A (zh) 2001-07-18
NO328444B1 (no) 2010-02-22
BR9910893B1 (pt) 2013-10-29
ITMI981312A1 (it) 1999-12-10
MXPA00012177A (es) 2004-09-06
KR100627933B1 (ko) 2006-09-22
US6656510B2 (en) 2003-12-02
CA2334308C (en) 2009-06-02
CZ298859B6 (cs) 2008-02-27
EP1086071A1 (en) 2001-03-28
WO1999064388A1 (en) 1999-12-16
CA2334308A1 (en) 1999-12-16
KR20010052637A (ko) 2001-06-25
NO20006230D0 (no) 2000-12-07
EP1086071B1 (en) 2005-10-19

Similar Documents

Publication Publication Date Title
BR0111639A (pt) Uso de uma molécula de ácido oligodeoxinucléico, e composição farmacêutica contendo a mesma
KR870700620A (ko) 신규 약리학적 화합물
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AU2420897A (en) Meta-substituted phenylene sulphonamide derivatives
EE04613B1 (et) Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
AU3354895A (en) Novel medicinal use of 5ht3 antagonist
BE2014C034I2 (en) Derivatives of 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems
HUP0003571A2 (hu) 6,9-Hídkötésű eritromicin-származékok
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
PL344696A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
NO306116B1 (no) Ny benzotiadiazinforbindelse og farmasöytiske sammensetninger
CA1271747C (en) BENZAZEPINE DERIVATIVES
PT870761E (pt) Derivados de tiocolchicina com actividades anti-inflamatoria e relaxante muscular
DE50101861D1 (de) Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung
EP0889033A4 (it)
DE69600231D1 (de) N-Arylalkylphenylacetamidderivate
RS50033B (sr) Derivati etansulfonil-piperidina
AU2549099A (en) 24-hydroxyvitamin d derivatives
AU4609701A (en) Colouring agent for keratin containing fibres
AU4956193A (en) Stable, highly concentrated formulations of fluorescein derivatives
WO2001083423A3 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
WO2000075158A3 (en) NOVEL 6-PHENYLPURINE 9-β-D-RIBONUCLEOSIDES WITH ANTINEOPLASTIC ACTIVITY, THEIR USE FOR PREPARING PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
AU579416B2 (en) 3-Amino-2,3-dihydro-1-benzoxepine-compounds and methods for their preparation and pharmaceutical preparations containing these compounds
ATE241604T1 (de) Polyhydroxyalkylpyrazine derivate und deren herstellung und diese enthaltende arzneimittel

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed